A Canadian Study Assessing the Utility of the Treatment Optimization Recommendations in Multiple Sclerosis
Clinical trial NCT01142583 · COMPLETED
Trial details
- NCT number
- NCT01142583
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2006-07-01
- Primary completion
- 2009-08-01
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.